• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Predictive Genetic Testing and Consumer Wellness Genomics Market

    ID: MRFR/LS/9360-HCR
    120 Pages
    Rahul Gotadki
    September 2025

    Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/Prostate Cancer Screening, Orthopedic & Musculoskeletal, ...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Predictive Genetic Testing and Consumer Wellness Genomics Market Summary

    Key Market Trends & Highlights

    Predictive Genetic Testing and Consumer Wellness Genomics Market Trends

    Predictive Genetic Testing and Consumer Wellness Genomics Market Drivers

    Market Segment Insights

    Regional Insights

    Industry Developments

      • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
      • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
      • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
      • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
      • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.

    Market Segmentation

    Europe

    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    Asia-Pacific

    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    By Test Type

    • Predictive Testing
    • Consumer Genomics
    • Wellness Genomics

    North America

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    By Setting Type

    • Proteomic Testing
    • Metabolic Testing
    • Genomic Testing

    Rest of the World

    • Middle East
    • Africa
    • Latin America 

    By Application type

    • Breast & Ovarian Cancer
    • Cardiovascular Screening
    • Colon Cancer
    • Others

    List of companies covered in this report:

    • 23andMe, Inc. (California)
    • Myriad Genetics, Inc. (US)
    • Hoffmann-La Roche Ltd. (Switzerland)
    • Abbott Laboratories (US)
    • Genesis Genetics (US)
    • Agilent Technologies (US)
    • Thermo Fisher Scientific, Inc. (US)
    • Bureau Gravimétrique International (China)
    • Bio-Rad Laboratories Inc. (US)
    • Illumina, Inc. (US)
    • Counsyl, Inc. (California)
    • ARUP Laboratories  (US)
    • Others

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Region

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    Predictive Genetic Testing & Consumer/Wellness Genomics Recent Developments

    • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
    • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
    • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
    • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
    • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Test Type

    • Wellness Genomics
    • Nutria Genetic
    • Skin & Metabolism Genetics
    • Others
    • Consumer Genomics
    • Predictive Testing
    • Genetic Susceptibility Test
    • Predictive Diagnostic
    • Population Screening

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Application

    • Breast & Ovarian Cancer
    • Cardiovascular Screening
    • Diabetic Screening & Monitoring
    • Colon Cancer
    • Parkinsonism/Alzheimer’s Disease
    • Urologic Screening/Prostate Cancer Screening
    • Orthopedic & Musculoskeletal
    • Others

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Setting Type

    • Proteomic Testing
    • Metabolic Testing
    • Genomic Testing

    Report Scope

    Report Attribute/Metric Details
      Market Size   USD 11.2 Billion
      CAGR   5.4%
      Base Year   2022
      Forecast Period   2023-2032
      Historical Data   2021
      Forecast Units   Value (USD Billion)
      Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Test Type, Application, and Setting Type
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World
      Key Vendors   23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US)
      Key Market Opportunities   Rise of application in personalized medicine
      Key Market Drivers   Usage of predictive genetic testing & consumer/wellness genomics in various applications

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

    The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

    Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

    North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

    What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

    High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

    1. EXECUTIVE SUMMARY
    2. MARKET INTRODUCTION
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    3. RESEARCH METHODOLOGY
    4. Overview
      1. Data Mining
      2. Secondary Research
      3. Primary Research
        1. Primary Interviews and Information Gathering Process
        2. Breakdown
    5. of Primary Respondents
      1. Forecasting Application
      2. Market Size Estimation
        1. Bottom-Up Approach
        2. Top-Down Approach
      3. Data Triangulation
      4. Validation
    6. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    7. MARKET FACTOR ANALYSIS
    8. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
        1. Bargaining Power of Buyers
        2. Threat of New Entrants
    9. Threat of Substitutes
      1. Intensity of Rivalry
      2. Value Chain Analysis
      3. COVID-19 Impact Analysis
        1. Market Impact Analysis
        2. Impact
    10. on Supply Chain
      1. Regional Impact
        1. Opportunity and Threat Analysis
    11. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    12. BY TEST TYPE
      1. Overview
      2. Predictive Testing
        1. Genetic
    13. Susceptibility Test
      1. Predictive Diagnostic
        1. Population Screening
      2. Consumer Genomics
      3. Wellness Genomics
        1. Nutria Genetic
        2. Skin & Metabolism Genetics
        3. Others
    14. GLOBAL PREDICTIVE
    15. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION
    16. Overview
      1. Breast & Ovarian Cancer
      2. Cardiovascular Screening
      3. Diabetic Screening & Monitoring
      4. Colon Cancer
      5. Parkinsonism/Alzheimer’s
    17. Disease
      1. Urologic Screening/Prostate Cancer Screening
      2. Orthopedic
    18. & Musculoskeletal
      1. Others
    19. GLOBAL PREDICTIVE GENETIC TESTING
    20. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE
      1. Overview
    21. Proteomic Testing
      1. Metabolic Testing
      2. Genomic Testing
    22. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY REGION
      1. Overview
      2. North America
        1. US
        2. Canada
    23. Europe
      1. Germany
        1. France
        2. UK
        3. Italy
        4. Spain
        5. Rest of Europe
      2. Asia-Pacific
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
      3. Rest of the World
        1. Middle East
        2. Africa
        3. Latin America
    24. COMPANY LANDSCAPE
    25. Overview
      1. Competitive Analysis
      2. Market Share Analysis
    26. Major Growth Strategy in the Global Predictive Genetic Testing & Consumer/Wellness
    27. Genomics Market
      1. Competitive Benchmarking
      2. Leading Players in
    28. Terms of Number of Developments in the Global Predictive Genetic Testing & Consumer/Wellness
    29. Genomics Market
      1. Key developments and Growth Strategies
        1. New
    30. Product Launch/Service Deployment
      1. Merger & Acquisitions
    31. Joint Ventures
      1. Major Players
        1. Sales & Operating Income,
        2. Major Players R&D Expenditure. 2020
    32. COMPANY PROFILES
      1. 23andMe, Inc.
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Myriad Genetics, Inc.
      3. F.Hoffmann-La
    33. Roche Ltd.
      1. Abbott Laboratories
      2. Genesis Genetics
    34. Agilent Technologies
      1. Thermo Fisher Scientific, Inc.
      2. Bureau
    35. Gravimétrique International
      1. Bio-Rad Laboratories Inc.
    36. Illumina, Inc.
      1. Counsyl, Inc.
      2. ARUP Laboratories
    37. Others
    38. APPENDIX
      1. References
      2. Related Reports
    39. LIST
    40. OF TABLES
    41. GENOMICS MARKET SYNOPSIS, 2023–2032
    42. TESTING & CONSUMER/WELLNESS GENOMICS MARKET ESTIMATES & FORECAST, 2023–2032
    43. (USD MILLION)
    44. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    45. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    46. –2032 (USD MILLION)
    47. CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    48. MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    49. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    50. –2032 (USD MILLION)
    51. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    52. BY TEST TYPE, 2023–2032 (USD MILLION)
    53. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    54. (USD MILLION)
    55. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    56. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
    57. –2032 (USD MILLION)
    58. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    59. BY SETTING TYPE, 2023–2032 (USD MILLION)
    60. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032
    61. (USD MILLION)
    62. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    63. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
    64. –2032 (USD MILLION)
    65. CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    66. BY APPLICATION, 2023–2032 (USD MILLION)
    67. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    68. (USD MILLION)
    69. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    70. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    71. –2032 (USD MILLION)
    72. CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    73. BY TEST TYPE, 2023–2032 (USD MILLION)
    74. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    75. (USD MILLION)
    76. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    77. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
    78. –2032 (USD MILLION)
    79. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    80. BY SETTING TYPE, 2023–2032 (USD MILLION)
    81. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    82. MILLION)
    83. MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    84. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    85. (USD MILLION)
    86. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    87. OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY
    88. APPLICATION, 2023–2032 (USD MILLION)
    89. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    90. (USD MILLION)
    91. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    92. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    93. –2032 (USD MILLION)
    94. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    95. BY TEST TYPE, 2023–2032 (USD MILLION)
    96. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
    97. (USD MILLION)
    98. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    99. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
    100. –2032 (USD MILLION)
    101. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    102. BY SETTING TYPE, 2023–2032 (USD MILLION)
    103. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    104. MILLION)
    105. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    106. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
    107. –2032 (USD MILLION)
    108. & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    109. MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    110. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    111. (USD MILLION)
    112. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    113. KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    114. –2032 (USD MILLION)
    115. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    116. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    117. OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    118. BY APPLICATION, 2023–2032 (USD MILLION)
    119. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
    120. –2032 (USD MILLION)
    121. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
    122. MILLION)
    123. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    124. OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
    125. BY SETTING TYPE, 2023–2032 (USD MILLION)
    126. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032
    127. (USD MILLION)
    128. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    129. EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING
    130. TYPE, 2023–2032 (USD MILLION)
    131. & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    132. BY APPLICATION, 2023–2032 (USD MILLION)
    133. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    134. (USD MILLION)
    135. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    136. AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY
    137. APPLICATION, 2023–2032 (USD MILLION)
    138. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
    139. (USD MILLION)
    140. MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    141. GENOMICS MARKET
    142. TESTING & CONSUMER/WELLNESS GENOMICS MARKET
    143. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020
    144. MARKET SHARE, BY APPLICATION, 2020 (%)
    145. & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%)
    146. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE,
    147. BY REGION, 2020 (%)
    148. CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
    149. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION,
    150. GENOMICS MARKET SHARE, BY REGION, 2020 (%)
    151. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
    152. COMPANY SHARE ANALYSIS, 2020 (%)
    153. SNAPSHOT
    154. INC.: FINANCIAL OVERVIEW SNAPSHOT
    155. F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
    156. OVERVIEW SNAPSHOT
    157. GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT
    158. SWOT ANALYSIS
    159. INC.: FINANCIAL OVERVIEW SNAPSHOT
    160. SWOT ANALYSIS
    161. OVERVIEW SNAPSHOT
    162. ANALYSIS
    163. FINANCIAL OVERVIEW SNAPSHOT
    164. COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT
    165. ANALYSIS
    166. ARUP LABORATORIES: SWOT ANALYSIS

    Predictive Genetic Testing & Consumer/Wellness Genomics Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment

    No infographic available

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027